Zimmer Biomet Holdings (XSWX:ZBH) Growth Rank: 6 (As of Aug. 01, 2026) — Near Median

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XSWX:ZBH Zimmer Biomet Holdings Inc XSWX:ZBH
76 GF Score
Price CHF75.50
GF Value CHF101.70
! 3 Warning Signs
View Full Analysis

What is Zimmer Biomet Holdings Growth Rank?

Zimmer Biomet Holdings XSWX:ZBH -0.66% 76 Growth Rank is 6 as of Aug. 01, 2026, which is at its 10-year median of 6.00. GuruFocus rates XSWX:ZBH with a GF Score™ of 76/100 and a GF Value™ of CHF101.70. The stock has 3 warning signs investors should review.

Zimmer Biomet Holdings has the Growth Rank of 6.

GuruFocus Growth Rank measures the growth of a company in terms of its revenue and profitability, rated on a scale from 1 to 10. Historically, the companies with the highest growth ranks performed the best over the long term. It is calculated using the following criteria:

1. 5-year revenue growth rate, the higher, the better.
2. 3-year revenue growth rate, the higher, the better.
3. 5-year EBITDA growth rate, the higher, the better.
4. The predictability of 5-year revenue. The most consistent it is, the higher the rank.

A higher score reflects a greater ability to drive business growth, with companies considered to have strong and sustainable expansion potential. Conversely, a lower score indicates challenges in achieving consistent growth and scalability.

GuruFocus found that the Growth Rank is the second of the two most-sensitive parameters among the five parameters checked. Please click GF Score to see more details on GF Score's 5 Key Aspects of Analysis.

Please note that we are using the five-year EBITDA growth rate as a parameter, so the company needs to have had positive growth over that time. The reason we use EBITDA instead of earnings per share is that with EBITDA, we can rank a lot more companies since a company may have positive EBITDA but negative EPS. Since we are looking at the growth here, EBITDA gives us a pretty clear picture about the growth in the company's business operations.

Zimmer Biomet Holdings Growth Rank Related Terms

XSWX:ZBH vs STE, PEN, PODD: Growth Rank Comparison

For the Medical Devices subindustry, Zimmer Biomet Holdings's Growth Rank, along with its competitors' market caps and Growth Rank data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Zimmer Biomet Holdings Growth Rank vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Zimmer Biomet Holdings's Growth Rank distribution charts can be found below:

* The bar in red indicates where Zimmer Biomet Holdings's Growth Rank falls into.


XSWX:ZBH
76GF Score
Zimmer Biomet Holdings Inc XSWX:ZBH
Growth Rank is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Growth Rank →
What does a Growth Rank of 6 mean?
Zimmer Biomet Holdings (XSWX:ZBH) has a Growth Rank of 6 as of Aug. 01, 2026. Growth Rank measures the growth of a company in terms of its revenue and profitability. View historical data on Zimmer Biomet Holdings and its competitors. This is near median its historical median of 6.00. Over the past decade, Zimmer Biomet Holdings' Growth Rank has ranged from 2.00 to 8.00.
Is Zimmer Biomet Holdings' Growth Rank too high?
Zimmer Biomet Holdings' current Growth Rank of 6 is near median its 10-year median of 6.00. Over the past 10 years, this metric has ranged from a low of 2.00 to a high of 8.00. Overall, Zimmer Biomet Holdings has a GF Score™ of 76/100, reflecting its overall financial health beyond just this single metric.
How does Zimmer Biomet Holdings' Growth Rank compare to STE and PEN?
Zimmer Biomet Holdings' Growth Rank of 6 can be compared against companies in the Medical Devices & Instruments industry. Historically, Zimmer Biomet Holdings' own Growth Rank has ranged from 2.00 to 8.00 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Growth Rank for a Medical Devices & Instruments company?
A good Growth Rank depends on the Medical Devices & Instruments industry context. However, Growth Rank should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Growth Rank mean?
A high Growth Rank can signal that a stock is expensive relative to its fundamentals. Growth Rank measures the growth of a company in terms of its revenue and profitability. View historical data on Zimmer Biomet Holdings and its competitors. Zimmer Biomet Holdings's current Growth Rank is 6, which is near median its own 10-year median of 6.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Zimmer Biomet Holdings stock overvalued right now?
Zimmer Biomet Holdings (XSWX:ZBH) has a current Growth Rank of 6. The stock's GF Value™ is CHF101.70, compared to a current price of CHF75.50 — trading 25.8% below its estimated fair value. The current Growth Rank is 6, which is near median its 10-year median of 6.00. Zimmer Biomet Holdings' overall GF Score™ is 76/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Growth Rank calculated?
Growth Rank is calculated from a company's financial statements. For Zimmer Biomet Holdings (XSWX:ZBH), the current Growth Rank is 6 as of Aug. 01, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Zimmer Biomet Holdings (XSWX:ZBH) Overvalued in 2026?

Based on GuruFocus' analysis, Zimmer Biomet Holdings stock appears to be undervalued. The current stock price of CHF75.50 is trading 25.8% below its estimated GF Value™ of CHF101.70.

Key valuation signals for XSWX:ZBH:

  • Growth Rank: 6 (near median its 10-year median of 6.00)
  • GF Value™: CHF101.70 vs. price of CHF75.50 (25.8% below fair value)
  • GF Score™: 76/100 with 3 warning signs

No single metric tells the full story. See the XSWX:ZBH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Zimmer Biomet Holdings Business Description

Address 345 East Main Street, Warsaw, IN, USA, 46580
Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly two-thirds of total revenue is derived from sales of large joints; another fourth comes from extremities, trauma, sports medicine, and related surgical products. The firm spun out its dental and spine businesses in 2022.
76GF Score

Get the complete analysis for XSWX:ZBH

Growth Rank is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

CHF75.50
Price
CHF101.70
GF Value